Showing results (211-220 of 246) with videos related to
Sort By:
Pageof 25
The Lancet. Oncology|February 1, 2024
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysisAnja L Frei, Anthony McGuigan, Ritik R A K Sinha, et al.Journal of Diabetes Science and Technology|October 4, 2021
Continuous Ketone Monitoring Consensus Report 2021Kevin T Nguyen, Nicole Y Xu, Jennifer Y Zhang, et al.The Lancet. Gastroenterology & Hepatology|July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based seriesEnric Domingo, Carme Camps, Pamela J Kaisaki, et al.Nature Genetics|July 10, 2007
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21Ian Tomlinson, Emily Webb, Luis Carvajal-Carmona, et al.Nature Genetics|October 16, 2007
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer riskPeter Broderick, Luis Carvajal-Carmona, Alan M Pittman, et al.Nature Genetics|December 18, 2007
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer riskEmma Jaeger, Emily Webb, Kimberley Howarth, et al.Journal of Diabetes Science and Technology|May 30, 2025
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 DiabetesJulia K Mader, Jenise C Wong, Guido Freckmann, et al.FEBS Open Bio|February 12, 2026
Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation studyJoakim Kalsnes, Maria X Isaksen, Frida Julbø, et al.British Journal of Cancer|January 15, 2024
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysisGwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, et al.Gut|November 1, 2024
Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinomaYalin Tu, Haoran Wu, Chengpeng Zhong, et al.Pageof 25